ASAN FOUNDATION
- Country
- π°π·South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Conditions
- First Posted Date
- 2008-02-20
- Last Posted Date
- 2013-03-26
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT00618501
- Locations
- π°π·
Asan Medical Center - University of Ulsan College of Medicine, Seoul, Korea, Republic of
Study of Sunitinib Administered as 4/2 vs. 2/1 Schedule in Advanced Renal Cell Carcinoma (RCC)
- Conditions
- Interventions
- First Posted Date
- 2007-12-11
- Last Posted Date
- 2014-09-25
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 76
- Registration Number
- NCT00570882
- Locations
- π°π·
Yeungnam University Medical Center, Daegu, Korea, Republic of
π°π·Daegu Catholic University Hospital, Daegu, Korea, Republic of
π°π·Asan Medical Center, Seoul, Korea, Republic of
Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant
- Conditions
- First Posted Date
- 2007-12-07
- Last Posted Date
- 2013-03-26
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 18
- Registration Number
- NCT00569283
- Locations
- π°π·
Korea Research Institute of Bioscience and Biotechnology, Dajeon, Korea, Republic of
π°π·Asan Medical Center - University of Ulsan College of Medicine, Seoul, Korea, Republic of
Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP
- Conditions
- Interventions
- First Posted Date
- 2007-11-29
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 22
- Registration Number
- NCT00565370
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease
- First Posted Date
- 2007-08-27
- Last Posted Date
- 2013-03-26
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT00521430
- Locations
- π°π·
Asan Medical Center - University of Ulsan College of Medicine, Seoul, Korea, Republic of
Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients
- First Posted Date
- 2007-05-01
- Last Posted Date
- 2016-01-13
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 78
- Registration Number
- NCT00468078
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Paclitaxel Eluting Covered Metallic Stent for Unresectable Malignant Bile Duct Obstruction
- Conditions
- Interventions
- First Posted Date
- 2007-03-28
- Last Posted Date
- 2010-06-11
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 52
- Registration Number
- NCT00453076
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of
Overcome Biochemical Aspirin Resistance Through Cilostazol Combination
- First Posted Date
- 2007-03-13
- Last Posted Date
- 2010-01-18
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 244
- Registration Number
- NCT00446641
- Locations
- π°π·
Jae-Kwan Cha, Busan, Korea, Republic of
π°π·Kangdong Sacred Heart Hospital, Hallym University, Seoul, Korea, Republic of
π°π·Eulji University Hospital, Daejon, Korea, Republic of
Study of Pyridoxine for Hand-Foot Syndrome
- First Posted Date
- 2007-03-12
- Last Posted Date
- 2014-02-25
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 389
- Registration Number
- NCT00446147
Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer
- First Posted Date
- 2007-03-12
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 22
- Registration Number
- NCT00446290
- Locations
- π°π·
Asan Medical Center, Seoul, Korea, Republic of